to determine if a sustained-release form of the calcium entry blocker diltiazem would be a satisfactory substitute for the combination of beta-adrenergic blocking agent and thiazide diuretic in the treatment of systemic hypertension and angina pectoris , 38 patients were studied in a 4-center trial .
C0012373
diltiazem
C0020538
hypertension